Ms Vinita Kailasanath > Freshfields Bruckhaus Deringer LLP > Silicon Valley, United States > Lawyer Profile
Freshfields Bruckhaus Deringer LLP Offices
2710 Sand Hill Road
Menlo Park
California, 94025
CALIFORNIA
United States
- Firm Profile
- Go to...
Ms Vinita Kailasanath
Position
Partner
Career
Vinita Kailasanath has extensive experience in strategic intellectual property and data-driven transactions in life sciences and technology, and particularly at their intersection. Vinita leads the MedTech practice at Freshfields and has represented life sciences companies, technology companies, healthcare companies and providers, and investors in connection with the execution of their cutting-edge MedTech and digital health strategies in addition to many of their other complex licenses and collaborations, strategic investments, and R&D and supply agreements. Vinita has advised clients on transactions involving medical devices (including SaMD), wearables, mobile apps, telemedicine, artificial intelligence/machine learning (AI/ML), IoT, software, hardware, pharmaceutical products and biologics, and also routinely advises on the intellectual property aspects of mergers, acquisitions and joint ventures.
Vinita’s work across the life sciences and technology sectors makes her uniquely well-equipped to structure a wide variety of agreements to enable clients to develop, use, commercialize and protect innovative offerings. In doing so, she draws on her graduate degree in molecular and cellular biology and in-depth knowledge of intellectual property gained through a clerkship at the Court of Appeals for the Federal Circuit. She is well-versed in the business, regulatory environment, and goals of the healthcare sector, while also being deeply familiar with Software as-a-Service (“SaaS”), Infrastructure-as-a-Service (“IaaS”) and Platform-as-a-Service (“PaaS”) arrangements as well as other cloud and technology-related considerations.
Prior to becoming a lawyer, Vinita conducted graduate-level neuroendocrinology research; worked in the legal department of a leading alternative energy company specializing in the production of algal oils and bioproducts; and assisted pharmaceutical, biotech and medical device companies with product launches and other marketing and sales matters.
Memberships
Vinita is the co-chair of the Freshfields Asian, Pacific, South Asian American Employee Resource Group and was selected as a 2023 LCLD (Leadership Council on Legal Diversity) Fellow.
Education
- Stanford Law School, J.D., 2010
- Editor-in-Chief, Stanford Technology Law Review
- Stanford University, MS, Biological Sciences, 2004
Stanford University, BA, Human Biology, with honors and distinction, Phi Beta Kappa, 2004
Lawyer Rankings
United States > Healthcare > Life sciences
(Next Generation Partners)Freshfields Bruckhaus Deringer LLP represents life sciences clients on both the target and buyer side of transactions in the sector, and is also adept at overseeing licensing agreements and asset acquisitions between pharmaceutical companies. The practice also handles litigious matters, including government investigations into off-label marketing and fraud allegations, and defense of clients facing securities suits. New York’s Adam Golden heads the team, overseeing M&A, VC investments and licensing and cooperation agreements and advising on the IP aspects of such deals. Out of Silicon Valley, Vinita Kailasanath assists with transactions at the intersection of life sciences and technology, while Washington DC-based Kristen Riemenschneider represents biopharmaceutical clients in their transactional matters, including those where liaising with government bodies is required.
Lawyer Rankings
- Next Generation Partners United States > Healthcare > Life sciences
- Life sciences United States > Healthcare
Top Tier Firm Rankings
- M&A/corporate and commercial > Corporate governance
- Dispute resolution > International arbitration
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Tax > Financial products
Firm Rankings
- Dispute resolution > International litigation
- Tax > International tax
- Dispute resolution > M&A litigation: defense
- Dispute resolution > Securities litigation: defense
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Antitrust > Merger control
- Tax > US taxes: non-contentious
- International trade > CFIUS
- International trade > Customs, export controls and economic sanctions
- Dispute resolution > General commercial disputes
- Media, technology and telecoms > Technology transactions
- Healthcare > Life sciences
- Finance > Commercial lending
- M&A/corporate and commercial > Shareholder activism